Methane

Methane

SCHEMBL3560123

C.Nc1ncc(C(F)(F)F)cc1Cl

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
POLB P06746 2/20 0.57
KDM4E B2RXH2 2/20 0.57
PLAU P00749 1/20 0.53
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
GAA P10253 2/20 0.47
HTT P42858 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
MAPT P10636 3/20 0.44
LMNA P02545 1/20 0.44
GLA P06280 1/20 0.44
HPGD P15428 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL119730 0.98 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL30256557 0.82 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL18094306 0.82 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL24068078 0.82 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL20350719 0.79 TSHR (0.41) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
Methane SCHEMBL28200241 0.79 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL15181426 0.78 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL30762204 0.77 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL1716472 0.77 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2POLBKDM4EPLAU
SCHEMBL29414916 0.77 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2POLBKDM4EPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7795457-B2 antitumor agents; anticancer agents; structurally related to the leptomycin family; Leptolstatin KOSAN BIOSCIENCES INCORPORATED (US) 2010-09-14 US disclosed
EP-2124927-A2 CARBAMATE COMPOUNDS Kosan Biosciences Incorporated (US) 2009-12-02 EP disclosed
US-20080214617-A1 Carbamate compounds KOSAN BIOSCIENCES INCORPORATED 2008-09-04 US disclosed
WO-2008106047-A2 CARBAMATE COMPOUNDS KOSAN BIOSCIENCES INCORPORATED (US) 2008-09-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214617-A1 Carbamate compounds CPS1, RB1, PRMT1 ALDH1A1 2117/4885SMN1; SMN2 4526/4885POLB 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.